The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Compliance for Peptide Therapy and BPC 157 Holt Law Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences RFK Jr. & claimed regenerative peptides like BPC 157 The Niche